Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma

Table 2

Prognostic EMT-derived genes in the TARGET cohort.

Genes	Hazard ratio	95% lower confidence interval	95% upper confidence interval	value
RPS9	2.458541	1.15383	5.23857	0.01977
NACA	2.062809	1.072155	3.968812	0.030111
RPL31	1.680277	1.0025	2.816292	0.048903
RPS23	1.582119	1.016551	2.462348	0.042083
EIF4A1	1.937961	1.08181	3.471674	0.026127
RPL12	1.825521	1.014796	3.283939	0.044538
RPL36	1.802713	1.14667	2.834099	0.010684
RPL37A	1.925317	1.244403	2.978814	0.003262
RPL30	1.728499	1.013395	2.948215	0.044557
EEF1D	2.404885	1.289322	4.48567	0.005799
RPL34	1.591933	1.008351	2.513262	0.045971
EEF1B2	1.869724	1.109806	3.149981	0.018701
RPS19	2.010787	1.032395	3.916394	0.040005
RPS8	2.668652	1.469129	4.84757	0.001268
RPS28	1.782071	1.161261	2.734766	0.008189
RPL10	1.854512	1.061042	3.241354	0.030163
RPL17	1.641353	1.015359	2.653289	0.043159
RPS24	1.724982	1.073501	2.771832	0.024256
RPL35A	1.994541	1.117985	3.558361	0.01941
RPS29	1.749557	1.044543	2.930418	0.033539
RPS27	2.231872	1.311656	3.797681	0.003074
RPS6	2.021336	1.349611	3.02739	0.000639
RPL11	1.708468	1.002166	2.912551	0.049078
RPL10A	2.063278	1.076517	3.954529	0.029103
RPL21	2.199899	1.223921	3.95414	0.008404
RPS3	2.092433	1.247417	3.509873	0.005147
RPS27A	1.913786	1.113551	3.289098	0.018812
RPS7	1.752451	1.118447	2.745847	0.014344
RPS12	1.809168	1.044998	3.132147	0.034248
PABPC1	1.618195	1.005308	2.604728	0.047506
RPL3	2.218272	1.119994	4.393531	0.022315
RPL7	1.777043	1.066145	2.961965	0.027407
RPL13A	2.1936	1.139154	4.224085	0.01879